Literature DB >> 2768342

Thrombospondin modulates focal adhesions in endothelial cells.

J E Murphy-Ullrich1, M Höök.   

Abstract

We examined the effects of thrombospondin (TSP) in the substrate adhesion of bovine aortic endothelial cells. The protein was tested both as a substrate for cell adhesion and as a modulator of the later stages of the cell adhesive process. TSP substrates supported the attachment of some BAE cells, but not cell spreading or the formation of focal adhesion plaques. In contrast, cells seeded on fibrinogen or fibronectin substrates were able to complete the adhesive process, as indicated by the formation of focal adhesion plaques. Incubation of cells in suspension with soluble TSP before or at the time of seeding onto fibronectin substrates resulted in an inhibition of focal adhesion formation. Furthermore, the addition of TSP to fully adherent cells in situ or prespread on fibronectin substrates caused a reduction in the number of cells, which were positive for focal adhesions, although there was no significant effect on cell spreading. In a dose-dependent manner, TSP reduced the number of cells with adhesion plaques to approximately 60% of control levels. The distribution of remaining adhesion plaques in TSP-treated cells was also altered: plaques were primarily limited to the periphery of cells and were not present in the central cell body, as in control cells treated with BSA. The observed effects were specific for TSP and were not observed with platelet factor 4, beta-thromboglobulin, or fibronectin. The TSP-mediated loss of adhesion plaques was neutralized by the addition of heparin, fucoidan, other heparin-binding proteins, and by a monoclonal antibody to the heparin binding domain of TSP, but not by antibodies to the core or carboxy-terminal regions of TSP. The interaction of the heparin-binding domain of TSP with cell-associated heparan sulfate appears to be an important mechanistic component for this activity of TSP. These data indicate that TSP may have a role in destabilizing cell adhesion through prevention of focal adhesion formation and by loss of preformed focal adhesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768342      PMCID: PMC2115751          DOI: 10.1083/jcb.109.3.1309

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Cell attachment and fibrinogen binding properties of platelet and endothelial cell thrombospondin are not affected by structural differences in the 70 and 18 kDa protease-resistant domains.

Authors:  P Clezardin; M C Bourdillon; N R Hunter; J L McGregor
Journal:  FEBS Lett       Date:  1988-02-15       Impact factor: 4.124

2.  Thrombospondin binding by human squamous carcinoma and melanoma cells: relationship to biological activity.

Authors:  B L Riser; J Varani; K O'Rourke; V M Dixit
Journal:  Exp Cell Res       Date:  1988-02       Impact factor: 3.905

3.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

Authors:  R P Penttinen; S Kobayashi; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Endothelial cell thrombospondin and its possible role in cell adhesion.

Authors:  J Lahav; R Dardik; O Stein
Journal:  Semin Thromb Hemost       Date:  1987-07       Impact factor: 4.180

5.  Thrombospondin in early human wound tissue.

Authors:  G J Raugi; J E Olerud; A M Gown
Journal:  J Invest Dermatol       Date:  1987-12       Impact factor: 8.551

6.  Thrombospondin-induced adhesion of human keratinocytes.

Authors:  J Varani; B J Nickoloff; B L Riser; R S Mitra; K O'Rourke; V M Dixit
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells.

Authors:  B Herman; M W Roe; C Harris; B Wray; D Clemmons
Journal:  Cell Motil Cytoskeleton       Date:  1987

8.  Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis.

Authors:  J E Murphy-Ullrich; L G Westrick; J D Esko; D F Mosher
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

9.  Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.

Authors:  J E Murphy-Ullrich; D F Mosher
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

10.  Adhesion of glycosaminoglycan-deficient chinese hamster ovary cell mutants to fibronectin substrata.

Authors:  R G LeBaron; J D Esko; A Woods; S Johansson; M Höök
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  90 in total

Review 1.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

Authors:  J E Murphy-Ullrich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.

Authors:  L Chandrasekaran; C Z He; H Al-Barazi; H C Krutzsch; M L Iruela-Arispe; D D Roberts
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.

Authors:  A Bogdanov; E Marecos; H C Cheng; L Chandrasekaran; H C Krutzsch; D D Roberts; R Weissleder
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

5.  Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

Authors:  Anne R Diers; Brian P Dranka; Karina C Ricart; Joo Yeun Oh; Michelle S Johnson; Fen Zhou; Manuel A Pallero; Thomas M Bodenstine; Joanne E Murphy-Ullrich; Danny R Welch; Aimee Landar
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

6.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 7.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

8.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

10.  Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.

Authors:  J P Girard; E S Baekkevold; T Yamanaka; G Haraldsen; P Brandtzaeg; F Amalric
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.